Yasumasa Arai

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 2

Top Topics

Disease Activity

Juvenile Idiopathic Arthritis

Top Venues

BMC pharmacology & toxicology

This page only lists publications with an associated author ORCID identifier.

Publications

Takuma Yonemura, Rie Yazawa, Miwa Haranaka, Kazuki Kawakami, Masayuki Takanuma, Takumi Kanzo, Dimitris Stefanidis, Yasumasa Arai
Comparison of two biosimilarity studies of FKB327 with the adalimumab reference product: randomized phase 1 studies of single-blind, single-dose subcutaneous injection in healthy Japanese male participants. BMC pharmacology & toxicology 23 (1) (2022)
Mark C Genovese, Herbert Kellner, Yasumasa Arai, Rafael Muniz, Rieke E Alten
Long-term safety, immunogenicity and efficacy comparing FKB327 with the adalimumab reference product in patients with active rheumatoid arthritis: data from randomised double-blind and open-label extension studies. RMD open 6 (1) (2021)